癌に対するサメの軟骨

FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.

Radiation oncology (London, England)·2024

Comparative assessment of radiation therapy-induced vasculitis using [<sup>18</sup>F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapy.

European journal of nuclear medicine and molecular imaging·2023

CT for detection of malignant posterior intercostal lymph nodes in patients undergoing pre-operative staging for malignant pleural mesothelioma.

Lung cancer (Amsterdam, Netherlands)·2020

Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.

International journal of radiation oncology, biology, physics·2017

CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up.

Breast cancer research and treatment·2013

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Disrupting Bacterial Quorum Sensing: A Review of Protein Families and Natural Inhibitors for Combating Resistance.

Current topics in medicinal chemistry·2026

Design, Optimization and Physicochemical Characterization of Pectin-Based Nanoparticles for In Vitro Anticancer Evaluation Against HCT116 Colon Cancer Cells.

Current pharmaceutical design·2026

Integrative bioinformatics and in vivo validation suggest a potential role of <i>Cbr4</i> in alcohol use disorder through modulation of lipid metabolism and treg cell function in the central amygdala.

Frontiers in genetics·2026

Research progress of cuproptosis, ferroptosis, apoptosis, and autophagy in knee osteoarthritis.

Frontiers in cell and developmental biology·2026

Integrating multi-omics and machine learning to uncover CCL20 as a potential regulator of the immunosuppressive microenvironment in lung adenocarcinoma.

Frontiers in immunology·2026

Uncovering cellular perturbations and key mediator communications in liver cancer using single-cell RNA sequencing.

Frontiers in immunology·2026

関連する実験動画

癌に対するサメの軟骨

関連する概念動画

FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.

Comparative assessment of radiation therapy-induced vasculitis using [<sup>18</sup>F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapy.

CT for detection of malignant posterior intercostal lymph nodes in patients undergoing pre-operative staging for malignant pleural mesothelioma.

Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors.

Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.

CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Disrupting Bacterial Quorum Sensing: A Review of Protein Families and Natural Inhibitors for Combating Resistance.

Design, Optimization and Physicochemical Characterization of Pectin-Based Nanoparticles for In Vitro Anticancer Evaluation Against HCT116 Colon Cancer Cells.

Integrative bioinformatics and in vivo validation suggest a potential role of <i>Cbr4</i> in alcohol use disorder through modulation of lipid metabolism and treg cell function in the central amygdala.

Research progress of cuproptosis, ferroptosis, apoptosis, and autophagy in knee osteoarthritis.

Integrating multi-omics and machine learning to uncover CCL20 as a potential regulator of the immunosuppressive microenvironment in lung adenocarcinoma.

Uncovering cellular perturbations and key mediator communications in liver cancer using single-cell RNA sequencing.

関連する実験動画

癌に対するサメの軟骨

関連する概念動画

関連記事